Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Represents Cowen in Leveraged Recapitalization of Ricerca Biosciences

March 15, 2007

New York, NY, March 15, 2007 — Covington & Burling LLP represented Cowen Capital Partners LLC in its March 8 leveraged recapitalization of Ricerca Biosciences, LLC, including new equity and term facilities approaching US $50 million. Covington has represented Cowen in all of its prior investments in Ricerca Biosciences dating back to 2000.

Ricerca Biosciences is a contract drug development company, offering extensive drug development services that improve the odds of converting drug discovery leads to drug candidates. Ricerca also supports clinical trials through GMP API manufacture and bioanalytical services.

New York-based Cowen Capital Partners is the middle-market private equity affiliate of Cowen and Company LLC.

The Covington corporate team included partners Scott Smith and Peter Laveran and associates Peter Bogdanow, Rob Heller (tax), and Beatriz Martinez.

Share this article: